Research programme: cochlear hair cell regeneration - Decibel Therapeutics
Latest Information Update: 27 Sep 2023
At a glance
- Originator Decibel Therapeutics
- Class Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Sensorineural hearing loss
Most Recent Events
- 25 Sep 2023 Decibel Therapeutics has been acquired by Regeneron Pharmaceuticals
- 12 Apr 2023 Preclinical trials in Sensorineural hearing loss in USA (Parenteral) (Decibel Therapeutics pipeline, April 2023)